Search
-
Redefining risk in medical device markets in the time of Covid-19
Read our white paper to review key considerations for medical device companies to redefine risk, identify opportunities and adapt during Covid-19
-
Cliff’s Take: Jobs Supplant Health as Americans’ Top Concern
With new coronavirus cases peaking, America’s attention swivels back to the jobs agenda
-
High income households more likely to want business to reopen even if COVID-19 isn’t contained
Two in 5 high income respondents want economy to reopen, compared to a third of low-income.
-
How the Public Is Weighing the Personal Cost of Coronavirus Against the Economy
People want to open up the economy, but don’t necessarily want to risk going out themselves.
-
Evaluating and adapting your soon-to-launch pharma strategy
Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.
-
Assessing the risk profile of recently launched drugs
Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.
-
Building Blocks of Corporate Trust During the Crisis
Read why delivering on basic needs is most likely to yield positive reputational impact and long-term goodwill from customers and other stakeholders.
-
Ask Us Anything: America’s Adaptation to the Time of Coronavirus
View our on demand webinar examining how public mood is changing as a result of Covid-19.
-
Me and We: How brands can innovate for good
We are no longer simply looking out for ourselves; we’re looking out for our communities, our cities, our country, our world. Read how brands can innovate for good in a world of uncertainty.